1. Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia. Issue 5 (3rd May 2016) Authors: Müller, Dirk; Fischer, Kirsten; Kaiser, Peter; Eichhorst, Barbara; Walshe, Ronald; Reiser, Marcel; Kellermann, Lenka; Borsi, Lisa; Civello, Daniele; Mensch, Alexander; Bahlo, Jasmin; Hallek, Michael; Stock, Stephanie; Fingerle-Rowson, Günter Journal: Leukemia & lymphoma Issue: Volume 57:Issue 5(2016:May) Page Start: 1130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗